Evaluación del funcionamiento hepático en pacientes con VIH, del Hospital General de Tapachula Chiapas, que están bajo tratamiento antirretroviral

2009, Number SA

Bioquimia 2009; 34 (SA)

Chang RC, García HRF, Maldonado LMA, Silva VEC, Ramírez AFJ

Language: Spanish
References: 4
Page: 110
PDF size: 152.75 Kb.

Text Extraction

REFERENCES

Aceti A, et al. Hepatotoxicity development during antiretroviral therapy containing protease inhibitors in patients with HIV: The role of hepatitis B and C virus infection”. JAIDS. 2002 January 1; 29: 41-48.
Hill B, James MD, Sheffield S, Jeanne MD, Zeeman G, Gerda MD, et al. Hepatotoxicity With Antiretroviral Treatment of Pregnant Women. Department of Obstetrics and Gynecology, University of Texas Southwestern Medical Center, Dallas, Texas. Obstetrics & Gynecology. 2001; 98: 909-911. By the American College of Obstetricians and Gynecologists. Abstract disponible en:http://www.greenjournal.org/cgi/content/abstract/98/5/909
McGovern BH, et al. Esteatosis hepática asociada con fibrosis, uso de análogos de nucleósidos y hepatitis C genotipo 3 en personas con infección por VIH. Clinical Infectious Diseases. 2006; 43: 347-356.
Wnuk Gorzata AM. Liver damage in HIV-infected patients. Department of Infectious Diseases, Pomeranian University of Medicine, Szczecin, Poland. Med Sci Monit 2001; 7: 729-36.